The New Era of Clinical Trial, Monitoring Visits with TrialPal MOVI
In today’s hybrid and decentralized clinical trials, paper-based monitoring visits have become an operational and regulatory risk. Manual processes, lost documents, approval delays, and audit findings are costly obstacles that directly impact study timelines and budgets. You can start Monitoring Visits with TrialPal MOVI, a solution validated under FDA 21 CFR Part 11, CROs and sponsors can digitally transform their on-site and remote monitoring visits, achieving greater efficiency, full traceability, and regulatory compliance — all within one centralized platform.
The Hidden Cost of Paper-Based Monitoring
Industry data shows that:
- 42% of CRAs lose more than 2 hours per visit completing manual forms.
- 1 in 3 monitoring reports must be resubmitted due to missing signatures or illegible data.
- The average time from visit to final sponsor approval can take up to 28 days.
🔎 Real case: A monitor lost key documents during travel to a remote site, delaying the study for three weeks and generating critical findings during an FDA audit.
How TrialPal MOVI Transforms the Monitoring Process, start Monitoring Visits with TrialPal MOVI
End-to-End Digitalization
- Planning → Execution → Approval in a single platform.
- Online visit recording.
- Smart alerts for pending SDV (Source Data Verification) or protocol deviations.
Audit-Ready Traceability
Complete audit trail with time-stamped actions (who, when, what).
Full version history of documents and user activities.
Measurable Efficiency for CRAs and Sponsors
Up to 70% less time spent on report generation.
Secure, validated electronic signatures compliant with FDA 21 CFR Part 11.
Customizable dashboards with key KPIs: completed visits, critical findings, approval timelines.
Proven Results
A global CRO that implemented TrialPal MOVI in 2024 achieved:
- Reduced monitoring report approval time from 4 weeks to 48 hours.
- 100% compliance in recent regulatory audits.
- Thousands of dollars saved in paper, shipping, and rework within 6 months.
The Future of Clinical Monitoring Is Already Here. Monitoring Visits with TrialPal MOVI
Digital monitoring is no longer optional — it’s a strategic requirement for competitiveness, agility, and regulatory compliance in modern clinical research.
